-
DISCHARGE DISPOSITION AND NEED FOR ONGOING CARE FOLLOWING HOSPITALIZATION OF HIGH-RISK PATIENTS WITH HOSPITALACQUIREDPRESSURE INJURIES(HAPIS)
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN CLINICAL MANIFESTATIONS OF GOUT AND PATIENT REPORTED OUTCOME MEASURES: RESULTS OF A REAL-WORLD SURVEY IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
SHAME, EMBARRASSMENT, AND THREATS TO DATA VALIDITY DUE TO CONFUSING COA WORDING: EXPLORATION OF CONCEPTUAL OVERLAP IN CRITICAL COA TERMINOLOGY IN THE CONTEXT OF GLOBAL ADMINISTRATION - FROM THE LINGUISTS’ PERSPECTIVE
Mar 18, 2026, 21:38 PM -
A COMPREHENSIVE GLOBAL SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE OF RELAPSED/REFRACTORY AND POST-BRUTON TYROSINE KINASE INHIBITOR MANTLE CELL LYMPHOMA
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGY AND FUTURE BURDEN OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG ADULTS IN THE UNITED STATES: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
INCREMENTAL DIRECT AND INDIRECT COSTS OF SJOGREN'S DISEASE IN THE UNITED STATES: A RETROSPECTIVE ANALYSIS USING MARKETSCAN DATABASES
Mar 18, 2026, 21:38 PM -
DISPARITIES BY SOCIOECONOMIC STATUS IN TIME FROM DIAGNOSIS TO CURATIVE SURGICAL TREATMENT FOR EARLY-STAGE NON-SMALL CELL LUNG CANCER IN U.S. ADULTS
Mar 18, 2026, 21:38 PM -
GOAL INVENTORIES IN STANDARDIZED IMPLEMENTATION OF PERSONALIZED OUTCOME ASSESSMENTS USING GOAL ATTAINMENT SCALING: A LANDSCAPE ANALYSIS
Mar 18, 2026, 21:38 PM -
PATIENT DESCRIPTIONS OF THE BENEFITS OF A REDUCED CORNSTARCH DOSE REGIMEN IN A PHASE 3 TRIAL OF DTX401 FOR GLYCOGEN STORAGE DISEASE TYPE IA
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A PROFESSIONAL FRAMEWORK FOR MARKET ACCESS WITHIN THE PHARMACEUTICAL INDUSTRY: A MULTI-METHODS STUDY
Mar 18, 2026, 21:38 PM -
BIAS GAPS IN REAL-WORLD DATA-BASED ECONOMIC EVALUATIONS: UNDERREPORTING, WEAK CONTROL, AND THE NEED TO UPGRADE PROPENSITY SCORE PRACTICE
Mar 18, 2026, 21:38 PM -
HOSPITAL AND ICU ADMISSION FORECASTS FOR LRTIS AND COPD IN SWITZERLAND THROUGH 2035: PROJECTING DEMOGRAPHIC EFFECTS ON HEALTHCARE RESOURCE UTILISATION, INPATIENT EXPENDITURES, AND GREENHOUSE GAS EMISSIONS (BRONCH-2035)
Mar 18, 2026, 21:38 PM -
DOES YOUR 1-MILLION-MEMBER COHORT TELL THE WHOLE STORY? RETHINKING ELIGIBLE POPULATION ESTIMATION IN CHRONIC DISEASE BUDGET IMPACT ANALYSES IN THE US
Mar 18, 2026, 21:38 PM -
EVALUATION OF MACHINE LEARNING-ASSISTED RISK OF BIAS ASSESSMENTS FOR SUPPORTING SYSTEMATIC REVIEWS. A CASE STUDY OF A REVIEW IN MOVEMENT DISORDERS
Mar 18, 2026, 21:38 PM -
EVIDENCE-BASED BENEFIT-RISK ASSESSMENT OF THE RSVPREF VACCINE IN ADULTS AGED =60 YEARS
Mar 18, 2026, 21:38 PM -
EVALUATION OF OFF-THE-SHELF AGENT-BASED AI TOOL CLAUDE CODE FOR RAPID REPLICATION OF A PUBLISHED COST-EFFECTIVENESS MODEL
Mar 18, 2026, 21:38 PM -
MULTI-CRITERIA DECISION ANALYSIS IN HEALTH INTERVENTION PRIORITY SETTING FOR UNIVERSAL HEALTH COVERAGE IN KENYA: AN EXPLORATORY STUDY
Mar 18, 2026, 21:38 PM -
EARLY TOXICITIES AND ECONOMIC BURDEN OF CAR-T THERAPY IN THE UNITED STATES: A RETROSPECTIVE COHORT STUDY OF ICANS AND CRS USING OPTUM DATA
Mar 18, 2026, 21:38 PM -
A MOSAIC OF EVIDENCE: THE CLINICAL AND ECONOMIC BENEFITS OF CERAMIDE-INFUSED SKIN BARRIERS IN OSTOMY CARE
Mar 18, 2026, 21:38 PM -
THE UNINTENDED CONSEQUENCES OF THE INFLATION REDUCTION ACT ON BIOSIMILAR MARKET INCENTIVES AND MEDICARE SAVINGS
Mar 18, 2026, 21:38 PM
